Dermiply

Dermiply is a human cellular and tissue-based product (HCT/P) distributed by Halo Biologics, primarily utilized in wound management and regenerative medicine. It is a biological scaffold derived from human donor tissue, such as dermal or amniotic tissue, processed to maintain the structural integrity of the extracellular matrix (ECM). This matrix is rich in endogenous proteins, collagen, and growth factors that provide a natural environment conducive to cellular attachment, migration, and proliferation. Dermiply is designed to support the body's innate healing processes in chronic or complex wounds, such as diabetic foot ulcers and venous leg ulcers, by providing a protective barrier and a regenerative template for new tissue growth. It is regulated as an HCT/P and medical device depending on its specific clinical application and processing method.

Brand names

Dermiply

Other names

Dermiply HCT/P